Abstract
The purpose of this study was to analyze the pattern of uveitis in Behçet’s disease in Tunisia, North Africa. We retrospectively reviewed the clinical records of 62 patients (111 eyes) diagnosed with Behçet’s uveitis (BU) at the Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia, between January 1995 and December 2006. Forty-seven of 62 patients (75.8%) were men and 15 (24.2%) were women. Mean age at onset was 29.3 years. The average follow-up was 75.6 months. The most common extraocular clinical manifestations were recurrent oral ulcer in all patients and pseudofolliculitis in 52 patients (83.9%). Uveitis was bilateral in 79%. Initial best-corrected visual acuity was ≥20/40 in 41 affected eyes (36.9%) and <20/200 in 49 affected eyes (44.2%). Panuveitis (68 eyes, 61.3%) and posterior uveitis (38 eyes, 34.2%) were the most common forms, followed by anterior uveitis (five eyes, 4.5%). Retinal vasculitis was found in 89 eyes (80.2%). Most common complications included posterior synechiae (32.4%), cataract (31.5%), and cystoid macular edema (19.8%). Systemic corticosteroids were administered in 58 patients (93.5%). Immunosuppressive drugs were used in 22 patients (35.5%). Fifty-six affected eyes (50.5%) had final visual acuity ≥20/40 and 34 affected eyes (30.6%) had final visual acuity <20/200. In Tunisia, BU affects predominantly young men. Bilateral panuveitis associated with retinal vasculitis was the most common ocular manifestation. More than 50% of patients maintained a visual acuity of 20/40 or better, and immunosuppressive therapy probably contributed to the improvement of visual prognosis of these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Evereklioglu G (2005) Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50:297–350
Sakane T, Takeno M, Suzuki N et al (1999) Behçet’s disease. N Engl J Med 341:1284–1291
Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behçet’s disease in the 1980s and 1990s. Ophthalmology 111:810–815
B’chir Hamzaoui S, Harmel A, Bouslama K et al (2006) Behçet’s disease in Tunisia. Clinical study of 519 cases. Rev Med Interne 27:742–750
Khairallah M, Ben Yahia S, Ladjimi A et al (2007) Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye Jan 21(1):33–39
Zouboulis CC, Kötter I, Djawari D et al (1997) Epidemiological features of Amantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J 38:411–422
Muhaya M, Lightman S, Ikeda E et al (2000) Behcet’s disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148
Demiroglu H, Barista I, Dundar S (1997) Risk factor assessment and prognosis of eye involvement in Behçet’s disease in Turkey. Ophthalmology 104:701–705
Ozdal PC, Ortac S, Taskintuna I et al (2002) Posterior segment involvement in ocular Behcet’s disease. Eur J Ophthalmol 12:424–431
Ambresin A, Tao Tran V, Spertini F et al (2002) Behçet’s disease in western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53–63
Tugal-Tutkun I, Onal S, Yaycioglu AR et al (2004) Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380
Yang P, Fang W, Meng Q et al (2008) Clinical features of Chinese patients with Behçet’s disease. Ophthalmology 115:312–318
Daghfous MT, Ammar M, Kamoun M et al (1980) Clinical aspects and course of Adamantiades Behcet’s disease in Tunisia: a report on 41 cases. J Fr Ophtalmol 3(8–9):463–468
Ouazzani B, Benchekroun N, El Aouni A et al (1995) Outcome of Behcet disease in ophthalmological milieu in Morocco. J Fr Ophtalmol 18(2):124–127
International Study Group for Behçet’s Disease (1990) Evaluation of diagnostic (‘classification’) criteria in Behçet’s disease: toward internationally agreed criteria. Lancet 335:1078–1080
Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140(3):509–516
Sakamoto M, Akazawa K, Nishioka Y et al (1995) Prognosis factors of vision in patients with Behçet disease. Ophthalmology 102:317–321
Krause L (2005) Adamantiades-Behcet’s disease. Ophthalmologe 102:329–334
Yazici H, Yurdakul S, Hamuryudan V (1999) Behçet’s syndrome. Curr Opin Rheumatol 11:53–57
Barra C, Belfort R, Abreu MT et al (1991) Behçet’s disease in Brazil: a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 35:339–346
BenEzra D, Cohen E (1986) Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol 70:589–592
Lardenoye C, Kooij B, Rothova A (2006) Impact of macular edema on visual acuity in uveitis. Ophthalmology 113:1446–1449
Mochizuki M (1998) Up-to-date treatment for Behçet’s disease. Asian Med J 41:320–325
Kitaichi N, Miyazaki A, Stanford MR et al (2007) Ocular feartures of Behçet’s disease: an international collaborative study. Br J Ophthalmol 91:1579–1582
Tugal-Tutkun I, Mudun A, Urgancioglu M et al (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trial. Arthritis Rheum 52(8):2478–2484
Accorinti M, Pirraglia MP, Paroli MP et al (2007) Infliximab treatment for ocular and extraocular manifestations of Behçet’s disease. Jpn J Ophthalmol 51(3):191–196
Gul A (2007) Standard and novel therapeutic approaches to Behcet’s disease. Drugs 67(14):2013–2022
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khairallah, M., Attia, S., Yahia, S.B. et al. Pattern of uveitis in Behçet’s disease in a referral center in Tunisia, North Africa. Int Ophthalmol 29, 135–141 (2009). https://doi.org/10.1007/s10792-008-9203-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-008-9203-9